This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
G-Spring (2016-11-04)
- Starting date:
- November 4, 2016
- Posting date:
- November 16, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Natural health products
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-61090
Reason
The product is labelled to contain a prescription drug substance (L-Dopa).
Depth of distribution
Retailers
Affected products
G-Spring
DIN, NPN, DIN-HIM
No market authorizationDosage form
Capsules
Strength
Per 4 capsules (according to label):
- Vitamin D3 (as cholecalciferol) 1000IU
- L-Arginine Pyroglutamate 1000mg
- L-Lysine 1000mg
- Mucuna Pruriens (Velvet Bean) (50% L-dopa) 300mg
- Bacopa Monnieri 30:1 Extract 220mg
- Puerarin (Radix puerariae) 100mg
- L-Theanine 100mg
- DMAE Bitartrate 100mg
- Melatonin 20mg
- Piperine Extract (95%) 5mg
Lot or serial number
33682
Companies
- Recalling Firm
-
Magnum Nutraceuticals
White Rock
British Columbia
CANADA
- Marketing Authorization Holder
-
Magnum Nutraceuticals
White Rock
British Columbia
CANADA